Anesthesia: Clinical Trials

3 trials for Anesthesia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3

Follow Anesthesia: new trials by email Literature Review of Anesthesia trials Research Report on Anesthesia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus Blockade
Neosaxitoxin combined with bupivacaine low and epinephrine (T1), Bupivacaine low combined with epinephrine (C1), Bupivacaine high combined with epinephrine (C2) - Anesthesia, Anesthesia, Local
Phase 1TerminatedGrĂ¼nenthal GmbH2422018-01-302018-10-11
Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09
AR09 solution, placebo - Anesthesia
Phase 1TerminatedArbor Pharmaceuticals, Inc.172013-12-012022-04-13
Two Anesthetic Techniques in Magnetic Resonance Imaging (MRI)
dexmedetomidine, propofol - Magnetic Resonance Imaging, Anesthesia
Phase 1TerminatedChildren's Hospital Medical Center, Cincinnati982009-01-012020-09-21

Narrower conditions

Agnosia (1)

Broader conditions

Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Dexmedetomidine (1)  ·  Epinephrine (1)  ·  Propofol (1)  ·  Triiodothyronine (1)  ·  neosaxitoxin (1)

Sponsors

Arbor Pharmaceuticals, Inc. (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  GrĂ¼nenthal GmbH (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

David MacLeod, MD (1)

NIH funding

2016 (1)